The effects of metformin on fasting blood glucose, blood pressure, serum lipids, lipoproteins and body weight in type 2 diabetes mellitus

Journal of the College of Physicians and Surgeons Pakistan

Volumn 10, Issue 11, 2000, Pages 405-408

  Mughal, M A ^a   Mahar, S A ^a   Akhund, I A ^a   Maheri, W M ^a   Jan, M ^a  

^a ZIAUDDIN MEDICAL UNIVERSITY   (Pakistan)

Author keywords

Blood glucose; Body weight; Diabetes mellitus; Hyperglycemia; Metformin; Type 2

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; SULFONYLUREA; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL TRIAL; DIET; DISEASE DURATION; DRUG EFFECT; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MALE; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS;

EID: 0034536599     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Prevention of complications in non-insulin-dependent diabetes mellitus (NIDDM)
2. United Kingdom prospective diabetes study 17: A 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin diabetes mellitus
3. Mechanism of metformin action in non-insulin-dependent diabetes mellitus
4. Cellular mechanism of action of metformin
5. Biguanides and NIDDM
6. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of preparative ultra-centrifuge
7. Comparison of methods for the estimation of plasma low and very-low density lipoprotein cholesterol
8. Low dose metformin in the treatment of type II non-insulin-dependent diabetes: Clinical and metabolic evaluation
9. The UK prospective diabetes study. A review
10. Disparate effects of antidiabetic drugs on arterial contraction
11. High dietary salt enhances acute depressor responses to metformin
12. Metformin improves vascular function in insulin-resistant rats
13. Metformin for obese, insulin-treated diabetic patients: Improvement in glycemic control reduction of metabolic risk factors
14. Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations, A double blind controlled study
15. Biguanides and NIDDM
16. The deadly quart. Upper-body obesity, glucose intolerance, hypertriglyceridemia and hypertension
17. A role for insulin in the etiology and course of hypertension
18. Hypertension and hyperinsulinemia: A relation in diabetes but not essential hypertension
19. The effects of glibenclamide and metformin on serum lipoproteins in type 2 diabetes
20. Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients
21. The reduction of low-density lipoprotein cholesterol by metformin is maintained with long-term therapy
22. Effects of metformin on insulin resistance risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects: A study of two ethnic groups